Waters (WAT, Life Sciences Tools & Services) Stock Valuation & Fair Value Significantly overvalued
Waters (WAT, Life Sciences Tools & Services) trades at a blended P/E of 28.8, about 24% above its historical normal valuation, with a forward growth estimate of 12.0% and a PEG of 2.40. Analysts' one-year estimates have been hit 91% of the time.
The Street vs SeerForecast
Wall Street's mean price target for WAT is $436.00 across 23 analysts, 6.2% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.
Valuation flags
- Overvalued by 24%
Verdict history
tickerseer's rating has been significantly overvalued since 2026-06-03.
Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.
Frequently asked questions
Is Waters stock overvalued?
At a blended P/E of 28.8 versus its historical normal P/E of 23.3, Waters trades about 24% above its typical valuation, with a PEG of 2.40 on 12.0% forward growth. tickerseer currently rates it significantly overvalued.
What is Waters's fair value and PEG?
Waters trades at a blended P/E of 28.8 against a historical normal P/E of 23.3, a PEG of 2.40, and a forward growth estimate of 12.0%.
Has tickerseer's rating of Waters changed?
tickerseer's rating has been significantly overvalued since 2026-06-03.
What is the analyst price target for Waters?
The mean Wall Street price target for Waters is $436.00 across 23 analysts, 6.2% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Life Sciences Tools & Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. Educational content, not investment advice.